Medicine composition for asthma treatment and preparation method thereof

Abstract

The invention discloses a medicine composition for asthma treatment and a preparation method thereof.The medicine composition for asthma treatment is prepared from eburicoic acid, mangiferin, hyperoside, raffinose, isotaxiresinol, 3,4-dihydroxybenzaldehyde, geraniol, stachydrine, ketotifen, trumpet shell refined powder, heracleum repula root extract, quercetin, omega-3 fatty acid, vitamin A, vitamin C, vitamin E, a filling agent, an adhesive, a disintegrating agent and a lubricating agent.Western medicine and traditional Chinese medicine extract effective ingredients are combined, and the medicine composition has the effects of eliminating phlegm and removing stasis, resisting inflammation and anaphylaxis, achieving spasmolysis, relieving asthma and enhancing immunologic function, can relax bronchial smooth muscle, improve pulmonary ventilation and reduce airway resistance, also can restrain airway inflammation, maintain normal lung function, adjust body immunocompetence and reduce side effects of medicine, is used for preventing asthmatic attack and preventing or reducing the recurrence rate as much as possible, and achieves the purpose of consolidating treatment.

Description

technical field [0001] The invention relates to the technical field of respiratory medicine medicine, in particular to a pharmaceutical composition for treating asthma and a preparation method thereof. Background technique [0002] Asthma, also known as bronchial asthma, is caused by chronic airway inflammation involving a variety of cells, especially mast cells, eosinophils, and T lymphocytes. This inflammation is often accompanied by increased airway responsiveness, leading to recurrent attacks Symptoms such as wheezing, shortness of breath, chest tightness, or cough usually occur at night or in the early morning, and the airway is highly responsive to various stimuli. reverse. Over the past ten years, the prevalence and mortality of asthma in the United States, the United Kingdom, Australia, New Zealand and other countries have been on the rise. There are about 100 million asthma patients in the world, and it has become a major chronic disease that seriously threatens pu...

AI Technical Summary

Problems solved by technology

At present, the treatment of asthma is mainly based on the administration of bronchodilator drugs in the airway, which can effectively relieve the symptoms of patients at the time of onset, but with the in-depth research on the etiology and pathogenesis of bronchial asthma, it is recognized that asthma is a chronic airway Inflammation and the clinical characteristics of airway hyperresponsiveness, so there is a new concept in the prevention and treatment of asthma. It is believed that the treatment of bronchodilators alone is not comprehensive enough. Many asthma are caused by inflammation. Simply using Bronchodilators may cover up the development of inflammation, thereby aggravating the condition. Therefore, a drug that can effectively control inflammation, improve lung ventilation, and regulate physical fitness is needed, so as to prevent and reduce the number of attacks. This is what the present invention will study